Androgen deprivation therapy is a promising approach in RCC in which targeting the AR in RCC sensitizes the cells to RTKIs; one possible mechanism for this is through the hedgehog or PI3K signaling pathways [71]. Here, AR is linked to renal cell carcinoma.